|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma:a phase Ⅲ,double-blind,comparative trial显示文摘 | ROSEN LS GORDON D ANTONIO BS | 2001 | Cancer J2001，7，5： | 1 |
| 2 | Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors:a phase Ⅲ, double-blind, randomized trial--the Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group显示文摘 | Rosen LS Gordon D Tchekmedyian S | 2003 | J Clin Oncol2003，21，6： | 1 |
| 3 | Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: A phase Ⅲ, double - blind, randomized trial The Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group 显示文摘 | Rosen LS Gordon D Tchekmedyian S | 2003 | J Clin Oncol2003，21，16： | 1 |
| 4 | Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma:a randomized,double-blind,multicenter,comparative trial显示文摘 | Rosen LS Gordon D Kaminski M | 2003 | Cancer2003，98，8： | 1 |
| 5 | Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double-blind, multicenter, comparative trial显示文摘 | Rosen LS Gordon D Kaminski M | 2003 | Cancer2003，98，： | 1 |
| 6 | Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma:A phase Ⅲ double-blind,comparative trial显示文摘 | Rosen LS Gordon D Antonio BS | 2001 | Cancer J2001，7，5： | 1 |
| 7 | Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with none-small cell lung carcinoma and other solid tumors:a randomized,phase Ⅲ,double-blind,placebo-controlled trail显示文摘 | Rosen LS Gordon D Tchekmedyian NS | 2004 | Cancer2004，100，： | 1 |
| 8 | Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase Ⅲ , double-blind, ran domized trial-the zoledronic acid Lung cancer and other solid tumors study group显示文摘 | Rosen LS Gordon D Tchekmedyian S | 2003 | J Clin Oncol2003，15，16： | 1 |
| 9 | Long- term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with non - small cell lung carcinoma and other solid tumors a randomized, phase Ⅲ double - blind, placebo - con -trolled trial显示文摘 | Rosen LS Gordon D Tchekmedyian NS | 2004 | Cancer2004，100，12： | 1 |
| 10 | Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: A phase Ⅲ, double-blind, comparative trial 显示文摘 | Rosen LS Gordon D Kaminski M | 2001 | Cancer J2001，7，7： | 1 |
| 11 | Zoledronic acid issuperior to pamidronate for the treatment of bone metastases inbreast carcinoma patients with at least one osteolytic lesion 显示文摘 | Rosen LS Gordon DH Dugan W Jr | 2004 | Cancer2004，100，1： | 1 |
| 12 | Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesion显示文摘 | Gordon DH Dugan W Jr at al | 2004 | Cancer2004，100，1： | 1 |
| 13 | Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treat- ment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double-blind,multicen- ter, comparative trial显示文摘 | Rosen LS Gordon D Kaminski M | 2003 | Cancer2003，98，8： | 1 |
| 14 | Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with none-small cell lung carcinoma and other solid tu- mors: a randomized, phasem, double-blind, placebo-controlled trail 显示文摘 | Rosen LS Gordon D Tchekmedyian NS | 2004 | Cancer2004，100，： | 1 |
| 15 | Eong-term efficacy and safety of zole-dronic acid in the treatment of skeletal metastases in patients with nonsmallcell lung carcinoma and other solid tumors: a randomized, Phase Ⅲ, double-blind, placebo-controlled triM显示文摘 | Rosen LS Gordon D Tchekmedyian NS | 2004 | Cancer2004，100，12： | 1 |
| 16 | Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinema patients with at least one osteolytic lesion 显示文摘 | Rosen LS Gordon DH Dugan W Jr | 2004 | Cancer2004，100，1： | 1 |
| 17 | Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast caner or osteolytic lesions of multiple myeloma: a phase ill, double-blind, comparative trial显示文摘 | Rosen LS Gordon D Kaminski M | 2001 | Cancer 12001，7，5： | 1 |
| 18 | Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial-the Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group 显示文摘 | Rosen LS Gordon D Tehekmedyian S | 2003 | J Clin Oncol2003，21，16： | 1 |
| 19 | Zoledronic acid versus pamidronate in the treatment of skeletal metastases inpatients with breast cancer or osteolytic lesions of multiple myeloma: a phaseⅢ, double-blind, comparative trial 显示文摘 | Rosen LS Gordon D Kaminski M | 2001 | Cancer J2001，7，5： | 1 |
| 20 | Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double- blind, multicenter, comparative trial显示文摘 | Rosen LS Gordon D Kaminski M etal | 2003 | Cancer2003，98，8： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员